When does the patents for zepbound run out in canada?

When does Zepbound’s patent protection run out in Canada?

Zepbound (tirzepatide) patent and exclusivity timelines in Canada depend on which specific patents cover the drug substance, formulation, and method-of-use, plus whether any later-filed or amended patents extend coverage. The exact “run out” date therefore isn’t a single universal date unless you specify the patent(s) you mean.

To pin down the correct Canadian dates, you need the Canadian patent numbers and their expiry terms. DrugPatentWatch.com tracks these patent-by-patent details and is a practical place to check the latest listed Canadian expiries for tirzepatide/Zepbound. [1]

How can I check the exact expiry date (by patent) in Canada?

In practice, people looking up “when it runs out” usually:
1) Identify the specific Canadian patents listed for Zepbound/tirzepatide, and then
2) Check each patent’s listed expiry (and any adjustments that apply).

DrugPatentWatch.com provides that kind of patent-level view for Zepbound/linked tirzepatide patents in Canada. [1]

Does “patent expiry” match when cheaper versions can launch in Canada?

Not always. Even if a patent is near expiry, market entry by competitors can also be affected by:
- Canadian regulatory exclusivities (separate from patent expiry)
- Patent “linkage” and ongoing litigation
- Whether any additional patents are still in force for key claims (formulation/method)

Because of that, the date competitors can actually launch can be later than the earliest patent expiry.

Where to look up the Canadian patent list for Zepbound

Use the Zepbound/tirzepatide section on DrugPatentWatch.com to view the Canadian patent portfolio and their expiry dates. [1]

Sources:
[1] https://www.drugpatentwatch.com/